We describe a method for continuous kinetic meastu-ement of hexosaminidase activity, and have applied it to detection of heterozygotes for Tay-Sachs gene. In contrast to existing single-point methods, a pH of 4.5, which is optimal for hexosaminidase activity on the substrate (4-methylumbelliferyl-N-acetyl-fl-o-glucosaminide) is maintained while the increase in fluorescence produced by 4-methylumbelliferone, the reaction product, is being determined. Under the conditions described the reaction follows zero-order kinetics, and activity is linearly related to serum dilution. There is a fairly narrow but practicable range of optimal substrate concentration. The presence of substrate in concentrations exceeding 1 mmol/liter results in progressive quenching of fluorescence and a decrease in apparent enzyme activity. The procedure is standardized with 4-methylumbelliferone in a solution of the substrate. This method is adaptable to use with automated multiple-point discrete-sample devices and especially with the fluorometric kinetic analyzers now being developed.
, the importance of screening for the carrier state in selected populations has been widely recognized and implemented.
Heterozygote screening has been coupled with the identification in utero of fetal Tay-Sachs homozygotes in "carrier couple" pregnancies by various methods of analysis of amniotic fluid for hexosaminidase activity. Existing manual and automated techniques for Tay-Sachs screening are variations of the original method of O'Brien et al. (3) . This method and its automated variations (4) (5) (6) are two-step procedures in which the enzyme is allowed to react with the substrate (4-methylumbelliferyl-N-acetyl--D-glucosaminide) at pH 4.5, the optimum pH for enzyme activity. The increment in fluorescence resulting from the liberation of 4-methylumbelliferone is then measured in another buffer system at pH 10.4. Enzymatic activity ceases at pH 10.4; therefore the method is inherently a singlepoint determination of enzyme activity. We describe here a fully kinetic approach to hexosaminidase activity determination in serum and leukocyte eluates. The method requires only commercially available equipment.
It is perhaps most suitably adaptable to the fluorometric fast kinetic analyzers now being developed.
Materials and Methods

Instrumentation
We used an Aminco fluoro-colorimeter (American Instrument Co., Silver Springs, Md. 20910) with a 20-sample water-jacketed changer, a Haake heating-cooling circulating water bath (Polyscience Corp., Evanston, Ill. 60204) at 37 #{176}C. The interference filters were: primary, 355 nm; secondary, 460 nm. We used a single-pen chart recorder. belliferone per liter of substrate solution and is used frequently to check, and, if necessary, to calibrate instrument response.
Reagents
Methods
Heat inactivation.
Add 25 zl of serum to each of a pair of fluorometer tubes containing 475 zl of the citrate/HCI buffer. Inactivate hexosaminidase A by placing one pair of tubes into a 50 #{176}C water bath for 2 h (3). Heating in a 60#{176}C water bath for exactly 5 miii (7) with subsequent centrifugation of the precipitated proteins that form (at pH 4.5) at this higher temperature gives the same results with serum. Transfer 1.5 ml of the substrate (1 mmol/liter) into both heat-treated and untreated tubes and place the pairs of tubes into the 20-place water-jacketed turret of the instrument. Check instrumental response with standards or quinine initially and after each series of 20 samples (10 pairs) has been run. The reaction may be followed continuously on the chart recorder if desired. However, for routine determination of many samples, a multiple-point determination is made to permit a greater analysis rate with this Leukocyte eluates are prepared by standard methods (7) . To release their hexosaminidases, the isolated leukocytes are frozen and thawed five times, by use of solid CO2 and a water bath set at 37 #{176}C. After centrifugation, the supernatant fluid is analyzed in the same manner as described for serum. Heat inactivation of leukocyte eluates is done only at 50 #{176}C because of the apparent lability of tissue hexosaminidase B at 60 #{176}C (5) . Results are expressed as the percentage of the total hexosaminidase activity represented by hexosaminidase A.
Results
Analytical Variables
Standard curve. The standard curve, prepared from dilutions of 4-methylumbelliferone in a 0.75 mmol/liter solution of substrate at pH 4.5, is shown in Figure 1 .
Optimal pH for reaction. The optimal reaction pH, determined by measuring activity in substrates buffered from pH 3 to pH 6, was between 4.4 and 4.6, with a 50% (4-Methylumbelliferyl-N-acetyl-fl-o-glucosaminide decline in activity at ±1 pH unit beyond this range, virtually identical to the pH optimum described by O'Brien et al. (3) .
Effect of substrate concentration. Figure 2 shows the effect of substrate concentration on apparent total hexosaminidase activity, with use of a serum with an activity of 800 nmol of methylumbelliferone per milliter of serum per hour. There is a maximum and constant apparent activity at pH 4.5 when the substrate concentration in the reaction medium is between 0.5 and 1.0 mmol/liter.
Above this concentration there is apparent progressive inhibition of the reaction by the substrate.
The actual nature of this apparent inhibition was examined by measuring the fluorescence of various concentrations of substrate containing a constant amount of added methylumbelliferon (see Table 1 ). Substrate is fully dissolved at these higher concentrations by warming to 37 #{176}C. Increasing substrate concentration evidently quenches the measured fluorescence of 4-methylumbelliferone, an effect we also observed at pH 9.9 (substrate in 0.17 mmol/liter glycine carbonate buffer, pH 9.9).
Effect of serum dilution. The method is linear with enzyme concentration (serum dilutions) to at least 3000 nmol per rfil of serum per hour (Figure 3) . Sera with greater jnitial activities are diluted before analysis.
Precision. Precision was determined by measuring the percentage of hexosaminidase A in 20 pairs of sera. Pairs were divided and analyzed on different days after storage at -20 #{176}C. The range of pairs was 28 to 71% hexosaminidase A, the mean wis 50.8%, and the SD was 1.2%. Table 2 lists data obtained for normal adults, heterozygotes, and pregnant women. We found no overlap in values for hexosaminidase A activity between the carrier group and normals, either when expressed as percent hexosaminidase A or in terms of absolute activity of hexosaminidase A. Most of the carrier sera were kindly supplied to us by other laboratories, where they had been identified as such by existing methods.
Data on Patients
Most of the pregnant (5 to 9 months of gestation) women's sera have less than 50% hexosaminidase A, overlapping the percentage values for carriers. No such overlap occurs in this small series when hexosaminidase A activities are expressed in absolute units. No sera from pregnant carriers were available to us for measurement of absolute hexosaminidase A activities; therefore the significance of the above absence of overlap is open to question and further study. The percentage hexosaminidase A in leukocytes was normal in a!l pregnant women studied (range, 53 to 75% hexosaminidase A).
Discussion
The advantage of the described method for hexosaminidase determination is that it represents a fully kinetic analysis of this enzyme in serum. Because only a change in fluorescence is measured, the potential for interference from turbidity or extraneous fluorogenic substances in serum is decreased. The kinetics of hexosaminidase activity have been previously studied spectrophotometrically by using very high concentrations of hepatic and jackbean meal hexosaminidase (8) .
Although these data are revelant to an understanding of the kinetic properties of hexosaniinidase and its substrates, they cannot be fully applied to any fluorometric approach because of various influences on the measured fluorescence of the product 4-methylumbelliferone. Factors include: (a) considerable fluorescence of the substrate and (b) quenching of 4-methylumbelliferone fluorescence by substrate. Both of these factors vary with substrate concentration and with pH of the final measured solution. Empirically, one fmds a plateau of optimal substrate concentration between 0.5 and 1.0 mmol/liter. Primary standardization of the procedure through the use of 4-methylumbeiliferone standards in substrate is preferable to some existing end-point methods (5) that require secondary serum standards that have been previously analyzed by manual methods to determine absolute activity. Accurate primary standardization of the procedure allows routine expression of results in terms either of absolute units of hexosaminidase A activity or as percent of total activity. The latter mode of expression has been used almost exclusively in the literature to date, with the notable exception of the study of Lowden and LaRamee (9) . Close analysis of their data on 82 pregnant women (followed from 0 to 9 months of gestation) and 20 heterozygotes appears to show clear separation of these groups on the basis of absolute hexosaminidase A activities. In their series, hexosaminidase A values were virtually constant during the first four months of pregnancy and increased only slightly thereafter. Both their data and ours (Table 2 ) appear to give some support to the possible advantage of expressing results in absolute units of hexosaminidase A. In our (smaller) series the mean absolute activity of hexosaminidase A in 22 pregnant women is only slightly higher than that for normals, and clearly higher than the 16 carriers, but the mean total hexosaminidase activity is more than twice as great in pregnant women. Thus, expression of hexosaminidase A as percent of total gives deceptively low results, a problem that has been resolved mainly by measuring percent hexosaminidase .A in leukocyte eluates (7) or tears (10) . While it is certainly premature to draw conclusions from these data, the above results suggest to us that the range of serum hexosaminidase A should be more completely studied by a method capable of accurate determination of absolute activity in sera from pregnant heterozygotes, pregnant normal women, and nonpregnant normals. The substrate concentration we chose (0.75 mmol/ liter) allows a margin of concentration of 0.25 mmol/liter above that level at which substrate is depleted (0.5 mmol/liter) during reaction with a serum of average total activity. This excess is sufficient to allow the results, even from sera with high activities, to remain linear for several hours. During the 15-mm interval used in this analysis, results with serum of the highest available activity remain linear with dilution. It is miportant to measure sera with high total activities accurately, however the results are expressed, to avoid false-positive results.
The rate of analysis of this method is limited only by the restrictions of currently available instrumentation. With the Aminco fluorometer and accessories we used, the analysis rate is at most 40 samples per hour, not including sample and reagent preparation or interpretation of results, which must be derived from a stripchart recording. Although this rate is slower than existing continuous-flow end-point methods (4-6), fluorometric kinetic analyzers presently under development should facilitate the rate of analysis desirable for any large-scale screening procedure.
Other synthetic 4-methylbelliferyl 0-substituted glycoside substrates have been used for the study of enzyme deficiencies in a variety of genetic disorders, including Fabry's disease, Gaucher's disease, Hurler's disease, and metachromatic leukodystrophy. We suggest that this analytical approach may be applied to the kinetic determination of those enzymes. We also hope to apply this method to the study of changes in urinary hexosaminidase activity in renal disease, because high total activities are found in the kidney, and urinary hexosaminidase activity is reportedly increased at the start of a renal transplant rejection episode (11) .
